These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33065441)

  • 1. Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies.
    Solangi M; Kanwal ; Mohammed Khan K; Saleem F; Hameed S; Iqbal J; Shafique Z; Qureshi U; Ul-Haq Z; Taha M; Perveen S
    Bioorg Med Chem; 2020 Nov; 28(21):115605. PubMed ID: 33065441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
    Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
    Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.
    Dhameja M; Gupta P
    Eur J Med Chem; 2019 Aug; 176():343-377. PubMed ID: 31112894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and studies of thiazolidinedione-isatin hybrids as α-glucosidase inhibitors for management of diabetes.
    Kaur R; Kumar R; Dogra N; Kumar A; Yadav AK; Kumar M
    Future Med Chem; 2021 Mar; 13(5):457-485. PubMed ID: 33506699
    [No Abstract]   [Full Text] [Related]  

  • 5. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
    Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dithiocarbamate derivatives inhibit α-glucosidase through an apparent allosteric site on the enzyme.
    Ghani U; Ashraf S; Ul-Haq Z; Mujamammi AH; Özkay Y; Demirci F; Kaplancikli ZA
    Chem Biol Drug Des; 2021 Aug; 98(2):283-294. PubMed ID: 34047492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats.
    Taha M; Imran S; Salahuddin M; Iqbal N; Rahim F; Uddin N; Shehzad A; Khalid Farooq R; Alomari M; Mohammed Khan K
    Bioorg Chem; 2021 May; 110():104808. PubMed ID: 33756236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 2-acylbenzofuranes as novel α-glucosidase inhibitors with hypoglycemic activity.
    Spasov AA; Babkov DA; Prokhorova TY; Sturova EA; Muleeva DR; Demidov MR; Osipov DV; Osyanin VA; Klimochkin YN
    Chem Biol Drug Des; 2017 Dec; 90(6):1184-1189. PubMed ID: 28585419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, α-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: As potential leads for the management of type-II diabetes mellitus.
    Taha M; Rahim F; Imran S; Ismail NH; Ullah H; Selvaraj M; Javid MT; Salar U; Ali M; Khan KM
    Bioorg Chem; 2017 Oct; 74():30-40. PubMed ID: 28750203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
    Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
    Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
    Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
    Hussain F; Khan Z; Jan MS; Ahmad S; Ahmad A; Rashid U; Ullah F; Ayaz M; Sadiq A
    Bioorg Chem; 2019 Oct; 91():103128. PubMed ID: 31369977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Bis-indolylmethane sulfonohydrazides derivatives as potent α-Glucosidase inhibitors.
    Gollapalli M; Taha M; Ullah H; Nawaz M; AlMuqarrabun LMR; Rahim F; Qureshi F; Mosaddik A; Ahmat N; Khan KM
    Bioorg Chem; 2018 Oct; 80():112-120. PubMed ID: 29894890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indane-1,3-diones: As Potential and Selective α-glucosidase Inhibitors, their Synthesis, in vitro and in silico Studies.
    Mukhtar A; Shah S; Kanwal ; Hameed S; Khan KM; Khan SU; Zaib S; Iqbal J; Perveen S
    Med Chem; 2021; 17(8):887-902. PubMed ID: 32851965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
    Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents.
    Sayahi MH; Zareei S; Halimi M; Alikhani M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Faramarzi MA; Rastegar H; Taslimi P; Ibrahim EH; Ghramh HA; Larijani B; Mahdavi M
    Sci Rep; 2024 Jul; 14(1):15791. PubMed ID: 38982268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.
    Ritu ; Sharma P; Gupta GD; Asati V
    Bioorg Chem; 2023 Oct; 139():106750. PubMed ID: 37499530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.